サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1747879

個別化精神医療の世界市場

Personalized Psychiatry

出版日
ページ情報
英文 289 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
個別化精神医療の世界市場
出版日: 2025年06月13日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 289 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

個別化精神医療の世界市場は2030年までに75億米ドルに達する見込み

2024年に44億米ドルと推定される個別化精神医療の世界市場は、2024年から2030年にかけてCAGR 9.3％で成長し、2030年には75億米ドルに達すると予測されます。個別化精神医療製品は、本レポートで分析したセグメントの1つであり、CAGRは8.3%を記録し、分析期間終了時には43億米ドルに達すると予測されます。個別化精神医療サービス分野の成長率は、分析期間中CAGR 10.2%と推定されます。

米国市場は12億米ドル、中国はCAGR 12.6％で成長すると予測

米国の個別化精神医療市場は2024年に12億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに15億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは12.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.7%と8.1%と予測されています。欧州では、ドイツがCAGR約7.3%で成長すると予測されています。

世界の個別化精神医療市場- 主要動向と促進要因のまとめ

プレシジョン・メンタルヘルスへのシフトは精神科医療をどう変えるか？

精密精神医学としても知られる個別化精神医療は、遺伝子、神経生物学、環境データを活用し、個人に合った治療を導くことで、メンタルヘルス治療の展望を再定義しています。従来の精神科治療は、薬効のばらつき、試行錯誤の処方、よく理解されていない診断の境界線などに長い間悩まされてきました。個別化精神医療は、バイオマーカーに基づく診断、薬理ゲノム検査、神経画像に基づく治療計画によって、これらの限界を克服しようとしています。

神経科学とゲノミクスにおけるエビデンスの増加により、うつ病、統合失調症、双極性障害、不安障害などの疾患に対して、より的を絞ったアプローチが可能になりつつあります。多遺伝子リスクスコア、脳波に基づくパターン認識、機械学習モデルなどのツールは、精神医学的評価にますます組み込まれるようになっています。これらの進歩により、診断精度が向上し、副作用が減少し、治療成績が向上しています-特に治療抵抗性疾患や併存疾患を持つ患者において-。

なぜファーマコゲノミクスとデジタルフェノタイピングが精神医学の介入戦略を再構築するのか？

ファーマコゲノミクスは個別化精神医療の要となっており、個々の遺伝子プロファイルが精神科治療薬に対する反応にどのように影響するかについて、臨床医に実用的な洞察を提供しています。現在市販されている遺伝子パネルでは、CYP450酵素、セロトニントランスポーター、その他の薬力学的標的の変異が解析され、抗うつ薬、抗精神病薬、気分安定薬の選択と投与の指針となっています。このアプローチは、副作用を最小限に抑え、治療反応を速め、治験ベースの処方の負担を軽減します。

同時に、デジタルフェノタイピングは、スマートフォンのセンサー、音声分析、ウェアラブルデバイスなどを通じて、気分、認知、行動をリアルタイムで非侵襲的にモニタリングするツールとして普及しつつあります。これらの技術は継続的な行動データを生成し、再発の早期兆候を検出し、治療反応を測定し、適応的介入をサポートすることができます。デジタルバイオマーカーを臨床ワークフローに統合することで、動的でデータ駆動型の精神医療が可能になり、エピソード的な診察から、縦断的で患者に特化したケアへと移行します。

規制機関、償還制度、AIツールは臨床導入にどのような影響を与えているか？

規制の進展は、個別化精神医療における市場の成熟を促しています。FDAやEMAなどの機関は、薬理ゲノムに基づく医薬品表示や精神科医療におけるコンパニオン診断薬の承認を開始しています。米国では、CMSが一部の薬理遺伝学的検査に対する保険適用を拡大し、いくつかの民間保険会社が大うつ病性障害における有効な遺伝子パネルの保険償還を行っています。このような政策開発により、コンパニオン診断薬やAIを活用した意思決定支援ツールに対するより広範な臨床導入と投資が促進されつつあります。

AIと機械学習はまた、メンタルヘルス状態のより強固な予測モデルを促進し、早期介入と層別化されたリスク・プロファイリングを可能にしています。これらのアルゴリズムは、ゲノム、画像、EHR、ウェアラブル出力などのマルチモーダルなデータセットで訓練され、従来の診断カテゴリーに含まれるサブタイプを特定しています。このような精神医学の病態生理学の微妙な理解は、標的治療の開発を導き、クローズドループシステムで診断、治療、患者モニタリングを統合するプレシジョン・メンタルヘルス・プラットフォームの出現を支えています。

個別化精神医療市場の世界的成長の原動力は？

個別化精神医療市場の成長は、精神疾患の有病率の上昇、治療の個人差に対する意識の高まり、ゲノム、ニューロイメージング、デジタルヘルス技術の融合など、いくつかの要因によってもたらされます。主な成長要因は、価値観に基づく治療とアウトカム重視の償還に向けた世界のシフトであり、これは広範な薬物療法よりも正確で効果的な治療戦略を選好するものです。

ゲノム検査へのアクセスの拡大、デジタルヘルス新興企業の急増、産学連携の拡大は、個別化精神医学ツールの商業化を加速させています。さらに、生産性の損失、再発率、医療費に反映されるように、効果のない精神科医療の社会的コストは、利害関係者に予測的で個別化された治療モデルの採用を促しています。バイオマーカーを検証し、分類システムを改良する研究が進むにつれ、個別化精神医療は次世代精神医療の基礎となる要素になりつつあります。

セグメント

タイプ（製品、サービス、ソフトウェア）;治療領域（うつ病、不安障害、双極性障害、統合失調症、中毒、その他の治療領域）

調査対象企業の例（注目の43社）

  • 23andMe
  • AltheaDx, Inc.
  • Arcara Personalized Psychiatry
  • BrainsWay Ltd.
  • BrightQuest Treatment Centers
  • CBT Plus
  • Genomind
  • GreyBird Ventures
  • HMNC Holding GmbH
  • Karuna Therapeutics
  • Mindstrong
  • Myriad Genetics
  • Peak Mental Wellness
  • Pear Therapeutics
  • Spring Health
  • Starling Minds
  • Sunovion Pharmaceuticals Inc.
  • Tempus AI
  • WayForward
  • Woebot Health

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP35507

Global Personalized Psychiatry Market to Reach US$7.5 Billion by 2030

The global market for Personalized Psychiatry estimated at US$4.4 Billion in the year 2024, is expected to reach US$7.5 Billion by 2030, growing at a CAGR of 9.3% over the analysis period 2024-2030. Personalized Psychiatry Products, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$4.3 Billion by the end of the analysis period. Growth in the Personalized Psychiatry Services segment is estimated at 10.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 12.6% CAGR

The Personalized Psychiatry market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 12.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

Global Personalized Psychiatry Market - Key Trends & Drivers Summarized

How Is the Shift Toward Precision Mental Health Transforming the Practice of Psychiatry?

Personalized psychiatry, also known as precision psychiatry, is redefining the landscape of mental health treatment by leveraging genetic, neurobiological, and environmental data to guide individualized care. Traditional psychiatric treatment has long struggled with variability in drug efficacy, trial-and-error prescriptions, and poorly understood diagnostic boundaries. Personalized psychiatry seeks to overcome these limitations through biomarker-based diagnosis, pharmacogenomic testing, and neuroimaging-guided treatment planning-offering the potential to match the right intervention to the right patient at the right time.

Growing evidence in neuroscience and genomics is enabling more targeted approaches to disorders such as depression, schizophrenia, bipolar disorder, and anxiety. Tools like polygenic risk scores, EEG-based pattern recognition, and machine learning models are increasingly being integrated into psychiatric evaluations. These advancements are improving diagnostic accuracy, reducing adverse drug reactions, and enhancing therapeutic outcomes-particularly in patients with treatment-resistant conditions or comorbidities.

Why Are Pharmacogenomics and Digital Phenotyping Reshaping Psychiatric Intervention Strategies?

Pharmacogenomics has become a cornerstone of personalized psychiatry, offering clinicians actionable insights into how individual genetic profiles influence responses to psychiatric medications. Commercially available gene panels now analyze variations in CYP450 enzymes, serotonin transporters, and other pharmacodynamic targets, guiding the selection and dosing of antidepressants, antipsychotics, and mood stabilizers. This approach minimizes side effects, speeds up therapeutic response, and reduces the burden of trial-based prescribing practices.

Simultaneously, digital phenotyping is gaining traction as a real-time, non-invasive tool for monitoring mood, cognition, and behavior through smartphone sensors, voice analysis, and wearable devices. These technologies generate continuous behavioral data that can detect early signs of relapse, measure treatment response, and support adaptive interventions. Integration of digital biomarkers into clinical workflows is enabling dynamic, data-driven psychiatry that moves beyond episodic consultations toward longitudinal, patient-specific care.

How Are Regulatory Bodies, Reimbursement Systems, and AI Tools Influencing Clinical Adoption?

Regulatory progress is catalyzing market maturity in personalized psychiatry. Agencies such as the FDA and EMA have begun approving pharmacogenomic-based drug labeling and companion diagnostics in psychiatric care. In the U.S., CMS has expanded coverage for select pharmacogenetic tests, while several private insurers are reimbursing validated gene panels in major depressive disorder. These policy developments are encouraging broader clinical uptake and investment in companion diagnostics and AI-powered decision support tools.

AI and machine learning are also facilitating more robust prediction models for mental health conditions, enabling early intervention and stratified risk profiling. These algorithms are being trained on multimodal datasets-including genomics, imaging, EHRs, and wearable outputs-to identify subtypes within traditional diagnostic categories. This nuanced understanding of psychiatric pathophysiology is guiding the development of targeted therapies and supporting the emergence of precision mental health platforms that integrate diagnostics, therapeutics, and patient monitoring in a closed-loop system.

What’s Driving the Global Growth of the Personalized Psychiatry Market?

The growth in the personalized psychiatry market is driven by several factors including the rising prevalence of mental health disorders, growing awareness of interindividual treatment variability, and the convergence of genomics, neuroimaging, and digital health technologies. A primary growth driver is the global shift toward value-based care and outcome-driven reimbursement, which favors precise and effective treatment strategies over broad-spectrum pharmacotherapy.

Expanding access to genomic testing, proliferation of digital health startups, and growing academic-industry collaborations are accelerating the commercialization of personalized psychiatric tools. Moreover, the societal cost of ineffective psychiatric care-reflected in lost productivity, relapse rates, and healthcare expenditures-is incentivizing stakeholders to adopt predictive, personalized treatment models. As research continues to validate biomarkers and refine classification systems, personalized psychiatry is poised to become a foundational component of next-generation mental health care.

SCOPE OF STUDY:

The report analyzes the Personalized Psychiatry market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Products, Services, Software); Therapeutic Area (Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction, Other Therapeutic Areas)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • 23andMe
  • AltheaDx, Inc.
  • Arcara Personalized Psychiatry
  • BrainsWay Ltd.
  • BrightQuest Treatment Centers
  • CBT Plus
  • Genomind
  • GreyBird Ventures
  • HMNC Holding GmbH
  • Karuna Therapeutics
  • Mindstrong
  • Myriad Genetics
  • Peak Mental Wellness
  • Pear Therapeutics
  • Spring Health
  • Starling Minds
  • Sunovion Pharmaceuticals Inc.
  • Tempus AI
  • WayForward
  • Woebot Health

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Personalized Psychiatry - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Mental Health Treatments Propels Growth in Personalized Psychiatry Approaches
    • Expansion of Pharmacogenomic Testing Throws the Spotlight on Gene-Drug Interaction Profiling for Psychiatric Care
    • OEM Innovation in AI-Based Behavioral Analysis and Mood Tracking Enhances Tailored Therapy Plans
    • Growth in Use of Wearables and Mobile Apps Supports Continuous Monitoring and Response Optimization
    • OEM Development of Digital Biomarkers and Predictive Analytics Strengthens Early Intervention Capabilities
    • Surging Interest in Psychedelic-Assisted Therapies Fuels Precision-Based Dosing and Patient Matching Strategies
    • OEM Collaboration With Psychiatric Institutions and Genetic Labs Accelerates Research Translation to Clinical Use
    • Increasing Focus on Treatment-Resistant Depression Spurs Demand for Personalized Drug Response Tools
    • OEM Emphasis on Integrated Patient Profiling Across Clinical, Behavioral, and Genomic Data Enhances Decision-Making
    • Expansion of Telepsychiatry and Remote Mental Health Services Supports Digital Personalization Platforms
    • OEM Investment in Longitudinal Mental Health Data Models Enables Predictive Risk Assessment
    • Growth in Direct-to-Consumer Mental Health Diagnostics Encourages Patient Empowerment in Care Decisions
    • OEM Participation in Mental Health AI Consortia Supports Standardization of Algorithms and Clinical Outcomes
    • Surging Need for Adverse Event Prediction in Polypharmacy Cases Drives Use of Predictive Psychiatry Tools
    • OEM Development of Personalized CBT Protocols and AI-Driven Therapy Matching Enhances Efficacy
    • Increasing Payer and Government Support for Value-Based Mental Health Reimbursement Models Fuels Adoption
    • OEM Advances in Voice Analysis, Sleep Monitoring, and Micro-Expression Recognition Expand Non-Invasive Biomarkers
    • Rising Awareness of Comorbid Conditions Strengthens Demand for Integrated Personalized Care Pathways
    • OEM Entry Into Workplace Mental Wellness and Employer-Sponsored Care Programs Supports Commercial Scalability
    • Global Mental Health Burden and Treatment Gaps Propel Investment in Data-Driven, Personalized Psychiatric Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Personalized Psychiatry Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Personalized Psychiatry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Anxiety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Anxiety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Anxiety by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bipolar Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Bipolar Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Bipolar Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Schizophrenia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Addiction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Addiction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Addiction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • JAPAN
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • CHINA
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • EUROPE
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Personalized Psychiatry by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • FRANCE
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • GERMANY
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Personalized Psychiatry by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • INDIA
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Personalized Psychiatry by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Personalized Psychiatry by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030
  • AFRICA
    • Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030

IV. COMPETITION